Clinical safety and efficacy of a preloaded monofocal hydrophobic acrylic intraocular lens in a real-world population.

医学 人工晶状体 眼科 人工晶状体 白内障手术 视力 超声乳化术 验光服务 青光眼 眼压 人口
作者
Samuel Giles Latham,Francis Carr,Hala Ali,Vinod Gangwani
出处
期刊:BMC Ophthalmology [BioMed Central]
卷期号:21 (1): 1-7
标识
DOI:10.1186/s12886-021-02142-8
摘要

This study was designed to evaluate visual, refractive and safety outcomes in eyes after they underwent phacoemulsification and implantation of a preloaded monofocal hydrophobic acrylic intraocular lens. This was a single center observational study conducted at Ashford and St Peter’s Hospitals NHS Foundation Trust, United Kingdom. Patients were included if they had cataract extraction with in-the-bag implantation of the EyeCee® One preloaded intraocular lens from August to October 2019. Pre-operative, surgery-related and 2 weeks and 3 months post-operative data was collected. Surgeons at this trust were then asked to complete a feedback form to evaluate their experience of implanting the EyeCee® One. One hundred fifty-two eyes were included in the study. Ninety-four (62%) of these eyes had cataract but no concomitant ocular pathology that could potentially affect visual acuity. Three months post-operatively, 98.7% of all eyes had monocular CDVA ≤0.3 logMAR. 100% of the eyes without concomitant ocular pathology achieved this target. The mean CDVA of all eyes in this study improved from 0.43 ± 0.43 logMAR pre-operatively, to 0.05 ± 0.11 logMAR post-operatively (p < 0.05). The mean sphere and spherical equivalent values showed significant improvements (p < 0.05) and (p < 0.05). There were no intraoperative complications and 1.3% of patients reported complications 2 weeks post-operatively. All of the participating surgeons said they would use the EyeCee® One again with 64% providing an overall rating of ‘excellent’ for their experience of implanting this intraocular lens. This study indicates excellent post-operative visual acuity and refractive outcomes in eyes after EyeCee® One implantation. This is accompanied with very little risk of intraoperative and post-operative complications.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
drbrianlau完成签到,获得积分10
刚刚
科研通AI5应助BUAAzmt采纳,获得10
3秒前
Clark完成签到,获得积分10
3秒前
洋洋完成签到,获得积分10
4秒前
YHY完成签到,获得积分10
10秒前
深情安青应助斯文的傲珊采纳,获得10
11秒前
XIeXIe完成签到,获得积分10
12秒前
13秒前
15秒前
电池哥发布了新的文献求助10
17秒前
BUAAzmt发布了新的文献求助10
20秒前
从容谷菱完成签到 ,获得积分10
24秒前
Zheng完成签到 ,获得积分10
25秒前
独自受罪完成签到 ,获得积分10
26秒前
精明的书白完成签到,获得积分20
31秒前
共享精神应助DavidJin采纳,获得10
32秒前
bc应助电池哥采纳,获得20
37秒前
月夙完成签到,获得积分0
38秒前
勤劳紫青完成签到 ,获得积分10
43秒前
P2JY完成签到,获得积分10
45秒前
吃小孩的妖怪完成签到 ,获得积分10
47秒前
不想看文献完成签到 ,获得积分10
47秒前
摩卡摩卡完成签到,获得积分10
49秒前
50秒前
tahiti关注了科研通微信公众号
50秒前
HR112完成签到 ,获得积分10
50秒前
Sissi完成签到 ,获得积分10
51秒前
动听半雪完成签到,获得积分10
53秒前
周Z完成签到,获得积分10
54秒前
cbq完成签到 ,获得积分10
55秒前
动听半雪发布了新的文献求助10
56秒前
zxt完成签到,获得积分10
1分钟前
机智的乌完成签到 ,获得积分10
1分钟前
1分钟前
neckerzhu完成签到 ,获得积分10
1分钟前
bc应助忧心的寄松采纳,获得20
1分钟前
tahiti发布了新的文献求助30
1分钟前
Snowy周完成签到,获得积分10
1分钟前
winni完成签到,获得积分10
1分钟前
1分钟前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
the MD Anderson Surgical Oncology Manual, Seventh Edition 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3777734
求助须知:如何正确求助?哪些是违规求助? 3323199
关于积分的说明 10213148
捐赠科研通 3038520
什么是DOI,文献DOI怎么找? 1667445
邀请新用户注册赠送积分活动 798139
科研通“疑难数据库(出版商)”最低求助积分说明 758275